Timothy F. Nelson

Mr. Nelson has represented both purchasers and sellers in a wide variety of corporate transactions, including mergers, asset sales, stock purchases and spin-offs. He has advised clients with respect to potential impact of “golden parachute” termination agreements, permissible treatment of employee stock options and structure of retention and deal bonus arrangements.

Mr. Nelson frequently conducts reviews of corporate compensation programs to identify and correct change in control-related deficiencies in such arrangements, and has assisted publicly traded clients in the preparation of required executive compensation disclosure.

Mr. Nelson has advised a wide range of clients, including Gilead Sciences, Inc., WeWork Companies Inc. and Biogen, Inc.